Clik here to view.
A Strategy to Handle the Most Aggressive Breast Cancer: Triple-negative Tumors
Reporter: Venkat Karra, Ph.D. There is no good treatmnet for triple-negative breast cancer cells. The standard of care is combination chemotherapy, and although it has a good initial response rate, a...
View ArticleClik here to view.
microRNA Biomarker
microRNA Biomarker Reporter: Larry H Bernstein, MD, FCAP MicroRNA Molecule May Serve as Biomarker miRNA molecule called miR-7 decreased in highly metastatic cancer stem-like cells. February 18, 2013...
View ArticleClik here to view.
Cancer Genomic Precision Therapy: Digitized Tumor’s Genome (WGSA) Compared...
Curator: Aviva Lev-Ari, PhD, RN Dr. Charles Swanton, Cancer Research, UK’s London Research Institute explained in his March 29, 2013 interview for Science, that the cancer treatments often fail as a...
View ArticleClik here to view.
Tamoxifen’s Effectiveness: Decrease in Tissue Density by Mammography – 50%...
Reporter: Aviva Lev-Ari, PhD, RN Changes in breast density point to tamoxifen‘s effectiveness By Kate Madden Yee, AuntMinnie.com staff writer April 22, 2013 — If women being treated with tamoxifen...
View ArticleClik here to view.
Family History of Cancer may increase the Risk of Close Relatives developing...
Close relative of a breast cancer survivor had more than a two-fold increased risk of ovarian cancer compared to women with no family history of breast cancer. Reporter: Aviva Lev-Ari, PhD, RN July 24,...
View ArticleClik here to view.
Mutation D538G – a novel mechanism conferring acquired Endocrine Resistance...
Mutation D538G – a novel mechanism conferring acquired Endocrine Resistance causes a change in the Estrogen Receptor and Treatment of Breast Cancer with Tamoxifen Reporter: Aviva Lev-Ari, PhD, RN...
View ArticleClik here to view.
Targeting of GLUT1 Glucose Transporter
Targeting of GLUT1 Glucose Transporter Larry H. Bernstein, MD, FCAP, Curator LPBI Prolactin-induced Subcellular Targeting of GLUT1 Glucose Transporter in Living Mammary Epithelial Cells Arieh Riskin,...
View Article